Early Access — free while we kick the tires
EdgarHawk

Young Richard A

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-11

Companies

Company Buys Sells Direction
Camp4 Therapeutics Corp CAMP 1 0 Net buying

Activity

September 2025
high
Buy
15,151 shares
$24,999
Significance 7/10

Director Young Richard A bought 15.2K shares of CAMP at $1.65; 6 other insiders also bought within 14 days, cluster pattern amid 170.0K post-transaction holdings.

Director Young Richard A purchased 15,151 shares at $1.65 on 2025-09-11, increasing his holdings by 9.8% to 170,010 shares total. This transaction is part of a cluster pattern: 6 other insiders also bought within the past 14 days, indicating coordinated insider purchasing activity. The company is unprofitable (net income of $-12,587,000.00 over the most recent full fiscal year) but shows strong revenue growth of 86.3% year-over-year, with latest quarter revenue at $1,497,000.00. The stock has rebounded significantly in the short term (+101.4% over 30 days and +80.5% over 90 days) but remains -76.3% below its 52-week high of $11.74, trading at $2.78 currently. The convergence of multi-insider buying, strong revenue growth trajectory, and depressed valuation relative to recent range deserves investor attention to understand the insiders' rationale.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access